T1	Participants 54 84	chronic hepatic encephalopathy
T2	Participants 86 172	A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group
T3	Participants 292 335	chronic hepatic encephalopathy in cirrhosis
T4	Participants 337 569	After a 15-day run-in period with controlled diet (45-65 g protein), the patients were administered, in addition to their diet, branched-chain amino acids (0.24 g/kg, 30 patients) or an equinitrogenous amount of casein (34 patients)
